Key facts
- Ascendco Health’s last known valuation is $48.8M (Jul 2025).
- It has raised $5.3M across 2 recorded rounds; the latest was Seed Round ($4.8M) in Jul 2025.
- Notable investors include Matter (Consulting Services (B2B)).
- Ascendco Health has filed 4 Form Ds with the SEC since 2016, most recently Jul 2025 ($4.8M sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ascendco Health
Funding rounds
2 roundsAbout Ascendco Health
Developer of surgical instrument management software designed to ensure the right instruments are ready for surgery. The company's platform allows healthcare providers to manage, purchase, procure, and optimize surgical devices, enabling practitioners to get good guidance to help surgical departments.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2013
- Employees
- 44
- Website
- ascendcohealth.com/
- Ownership
- Privately Held (backing)
Ascendco Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ascendco Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ascendco Health in its N-PORT filings yet. We sweep new filings monthly.